ArticleAnnals of translational medicine2020

Comparison of radiofrequency ablation combined with sorafenib or sorafenib alone in patients with ECOG performance score 1: identifying optimal candidates.

Lei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.